tiprankstipranks
Trending News
More News >

InnoCare Pharma Schedules Board Meeting for Annual Results Approval

Story Highlights
InnoCare Pharma Schedules Board Meeting for Annual Results Approval

Don’t Miss TipRanks’ Half Year Sale

An update from InnoCare Pharma Ltd. ( (HK:9969) ) is now available.

InnoCare Pharma Ltd. has announced a board meeting scheduled for March 27, 2025, to consider and approve the annual financial results for the year ending December 31, 2024. This meeting is significant as it will impact the company’s financial disclosures and could influence stakeholder perceptions and market positioning.

More about InnoCare Pharma Ltd.

InnoCare Pharma Ltd. is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative drugs. The company operates in the healthcare industry, with a primary focus on creating treatments for cancer and autoimmune diseases.

YTD Price Performance: 42.65%

Average Trading Volume: 7,893,520

Technical Sentiment Consensus Rating: Sell

Current Market Cap: HK$13.14B

See more insights into 9969 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1